Cargando…
A stitch in time saves nine: external quality assessment rounds demonstrate improved quality of biomarker analysis in lung cancer
Biomarker analysis has become routine practice in the treatment of non-small cell lung cancer (NSCLC). To ensure high quality testing, participation to external quality assessment (EQA) schemes is essential. This article provides a longitudinal overview of the EQA performance for EGFR, ALK, and ROS1...
Autores principales: | Keppens, Cleo, Tack, Véronique, Hart, Nils ‘t, Tembuyser, Lien, Ryska, Ales, Pauwels, Patrick, Zwaenepoel, Karen, Schuuring, Ed, Cabillic, Florian, Tornillo, Luigi, Warth, Arne, Weichert, Wilko, Dequeker, Elisabeth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5945546/ https://www.ncbi.nlm.nih.gov/pubmed/29755669 http://dx.doi.org/10.18632/oncotarget.24980 |
Ejemplares similares
-
The Relevance of External Quality Assessment for Molecular Testing for ALK Positive Non-Small Cell Lung Cancer: Results from Two Pilot Rounds Show Room for Optimization
por: Tembuyser, Lien, et al.
Publicado: (2014) -
Accreditation, setting and experience as indicators to
assure quality in oncology biomarker testing laboratories
por: Tack, Véronique, et al.
Publicado: (2018) -
A stitch in time saves nine
por: Aggarwal, Ritu, et al.
Publicado: (2012) -
"A stitch in time saves nine"
por: Pieper, Michael
Publicado: (2021) -
PD-L1 immunohistochemistry in non-small-cell lung cancer: unraveling differences in staining concordance and interpretation
por: Keppens, Cleo, et al.
Publicado: (2020)